EA000740B1 - Способ получения твердого терапевтически активного лекарственного средства, содержащего лекарство в малых дозах, и лекарственное средство, полученное этим способом - Google Patents

Способ получения твердого терапевтически активного лекарственного средства, содержащего лекарство в малых дозах, и лекарственное средство, полученное этим способом Download PDF

Info

Publication number
EA000740B1
EA000740B1 EA199800179A EA199800179A EA000740B1 EA 000740 B1 EA000740 B1 EA 000740B1 EA 199800179 A EA199800179 A EA 199800179A EA 199800179 A EA199800179 A EA 199800179A EA 000740 B1 EA000740 B1 EA 000740B1
Authority
EA
Eurasian Patent Office
Prior art keywords
drug
carrier
pharmaceutical composition
mixture
excipient
Prior art date
Application number
EA199800179A
Other languages
English (en)
Russian (ru)
Other versions
EA199800179A1 (ru
Inventor
Джеймс Альберт Нэппер
Нил Мортимер
Карен Триона О'Браен
Султан Джеймс Манек
Раджиндер Кумар
Майкл Сидней Джордж Кларк
Джулия Мэри Лоудон
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA199800179A1 publication Critical patent/EA199800179A1/ru
Publication of EA000740B1 publication Critical patent/EA000740B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EA199800179A 1995-07-29 1996-07-29 Способ получения твердого терапевтически активного лекарственного средства, содержащего лекарство в малых дозах, и лекарственное средство, полученное этим способом EA000740B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process
PCT/EP1996/003326 WO1997004750A2 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs

Publications (2)

Publication Number Publication Date
EA199800179A1 EA199800179A1 (ru) 1998-10-29
EA000740B1 true EA000740B1 (ru) 2000-02-28

Family

ID=26307485

Family Applications (2)

Application Number Title Priority Date Filing Date
EA199800179A EA000740B1 (ru) 1995-07-29 1996-07-29 Способ получения твердого терапевтически активного лекарственного средства, содержащего лекарство в малых дозах, и лекарственное средство, полученное этим способом
EA199901055A EA199901055A1 (ru) 1995-07-29 1996-07-29 Фармацевтическая композиция для лечения и/или профилактики деменции

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA199901055A EA199901055A1 (ru) 1995-07-29 1996-07-29 Фармацевтическая композиция для лечения и/или профилактики деменции

Country Status (25)

Country Link
EP (1) EP0841902A2 (es)
JP (1) JPH11510493A (es)
KR (1) KR19990035972A (es)
CN (1) CN1196677A (es)
AP (1) AP858A (es)
AR (1) AR004178A1 (es)
AU (1) AU716961B2 (es)
BG (1) BG102266A (es)
BR (1) BR9609804A (es)
CA (1) CA2228048A1 (es)
CZ (1) CZ24798A3 (es)
DZ (1) DZ2077A1 (es)
EA (2) EA000740B1 (es)
HU (1) HUP9900521A3 (es)
IL (1) IL122897A0 (es)
MA (1) MA23953A1 (es)
MX (1) MX9800809A (es)
NO (1) NO980384L (es)
NZ (1) NZ315632A (es)
OA (1) OA10659A (es)
PL (1) PL325242A1 (es)
SK (1) SK11098A3 (es)
TR (1) TR199800156T1 (es)
UY (1) UY24297A1 (es)
WO (1) WO1997004750A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
US6451343B1 (en) * 1998-03-11 2002-09-17 Smithkline Beecham Corporation Composition for treating dementia and Alzheimer's disease
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
WO2002047693A2 (en) 2000-12-14 2002-06-20 Ortho-Mcneil Pharmaceutical, Inc. Steroid hormone products comprising a stabilizing agent in non-crystalline form
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
DK0392803T3 (da) * 1989-04-13 2004-10-18 Beecham Group Plc Hidtil ukendte forbindelser
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
CA2228048A1 (en) 1997-02-13
NZ315632A (en) 1999-11-29
CZ24798A3 (cs) 1998-06-17
WO1997004750A3 (en) 1997-03-27
BG102266A (en) 1998-10-30
BR9609804A (pt) 1999-07-06
CN1196677A (zh) 1998-10-21
EA199800179A1 (ru) 1998-10-29
OA10659A (en) 2002-09-18
EP0841902A2 (en) 1998-05-20
AP9801170A0 (en) 1998-01-31
UY24297A1 (es) 1997-01-23
AU6738496A (en) 1997-02-26
PL325242A1 (en) 1998-07-06
IL122897A0 (en) 1998-08-16
EA199901055A1 (ru) 2000-06-26
MX9800809A (es) 1998-04-30
AP858A (en) 2000-07-12
SK11098A3 (en) 1998-07-08
AU716961B2 (en) 2000-03-09
MA23953A1 (fr) 1997-04-01
HUP9900521A2 (hu) 1999-06-28
HUP9900521A3 (en) 2001-04-28
NO980384D0 (no) 1998-01-28
AR004178A1 (es) 1998-11-04
DZ2077A1 (fr) 2002-07-22
KR19990035972A (ko) 1999-05-25
NO980384L (no) 1998-03-26
JPH11510493A (ja) 1999-09-14
TR199800156T1 (xx) 1998-04-21
WO1997004750A2 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
KR100348842B1 (ko) 염기성물질로안정화된약제학적조성물
EP0847273B1 (en) Improved pharmaceutical ion exchange resin composition
US20090232897A1 (en) Pharmaceutical compositions comprising conjugated estrogens
NO311492B1 (no) Fremgangsmåte for fremstilling av doseringsenheter omfattende ett steroid progestogen, ved våtgranulering, samt tabletter derav
KR20010034573A (ko) 합성 천연 프로게스테론과 에스트라디올을 기초로 하는약학적 조성물과 그의 제조 방법
JP5627062B1 (ja) アミノカルボン酸の塩の固形組成物
US20020150618A1 (en) Process for preparing solid dosage forms of very low-dose drugs
CN111920778A (zh) 一种左乙拉西坦片及其制备方法
KR0170380B1 (ko) 고상 투여형용 안정화계
AU759869B2 (en) Pharmaceutical formulations
EA000740B1 (ru) Способ получения твердого терапевтически активного лекарственного средства, содержащего лекарство в малых дозах, и лекарственное средство, полученное этим способом
Kukkar et al. Mixing and formulation of low dose drugs: underlying problems and solutions
US8062664B2 (en) Process for preparing formulations of lipid-regulating drugs
SK50132006A3 (sk) Flukonazolové kapsuly so zlepšeným uvoľňovaním
CA2275626C (en) Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations
MXPA98000809A (es) Procedimiento para preparar formas de dosis solidas de dosis muy bajas del farmaco
JP2000239185A (ja) 医薬組成物
AU751607B2 (en) Method of treatment of dementia
KR920008161B1 (ko) 오메프라졸 경구용 약제의 제조방법
JPH08325142A (ja) ヨウ化イソプロパミド含有製剤
AU2019308862B2 (en) Solid pharmaceutical cytisine composition
US20120100211A1 (en) Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
JP2005529929A (ja) プロゲスターゲン投与単位
US20060177512A1 (en) Process for preparing formulations of lipid-regulating drugs
MXPA06000111A (es) Proceso para preparar formulaciones de farmacos que regulan lipidos.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU